Literature DB >> 2881925

The glycophospholipid anchor of Thy-1. Biosynthetic labeling experiments with wild-type and class E Thy-1 negative lymphomas.

S H Fatemi, R Haas, N Jentoft, T L Rosenberry, A M Tartakoff.   

Abstract

The Thy-1 antigen of the surface of lymphocytes and neurons is anchored to the plasma membrane via a glycophospholipid moiety. In contrast, the Thy-1 synthesized by the class E Thy-1 negative mutant lymphoma is secreted as a hydrophilic species. The present investigation uses the approach of biosynthetic labeling to investigate further the structure of the intracellular Thy-1 of wild-type cells and the secreted Thy-1 of these mutant cells. In the wild-type cells, Thy-1 can be labeled with [3H] mannose, [3H]galactose, [3H]fucose, [3H]ethanolamine, and [3H]palmitic acid. In the latter two cases the label is recovered almost exclusively in a detergent-binding Pronase fragment of the protein. The incorporated label is in the form of [3H]ethanolamine, or [3H]palmitate and stearate, respectively. Reductive methylation of biosynthetically labeled Thy-1 and a nonradioactive sample of Thy-1 shows that [3H]ethanolamine is incorporated equally into two residues of ethanolamine, only one of which has a free amino group. A single residue of glucosamine with a free amino group is also detected. Each of the sugar precursors is incorporated with extensive conservation of chemical identity. In the class E cells, each of the labeled sugars but neither [3H]ethanolamine nor [3H]palmitate is incorporated into Thy-1. The anchor moiety therefore appears to be entirely missing, although N-linked oligosaccharide processing is essentially normal. We postulate that the anchor deficiency in the mutant cells results from a biosynthetic lesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881925

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein.

Authors:  B Crise; A Ruusala; P Zagouras; A Shaw; J K Rose
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  No glycolipid anchors are added to Thy-1 glycoprotein in Thy-1-negative mutant thymoma cells of four different complementation classes.

Authors:  A Conzelmann; A Spiazzi; C Bron; R Hyman
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  Atypical mannolipids characterize Thy-1-negative lymphoma mutants.

Authors:  P Lemansky; D K Gupta; S Meyale; G Tucker; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Differences in the glycolipid membrane anchors of bovine and human erythrocyte acetylcholinesterases.

Authors:  W L Roberts; B H Kim; T L Rosenberry
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Characterization of [3H]palmitate- and [3H]ethanolamine-labelled proteins in the multicellular parasitic trematode Schistosoma mansoni.

Authors:  P M Wiest; E J Tisdale; W L Roberts; T L Rosenberry; A A Mahmoud; A M Tartakoff
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

7.  Addition of lipid substituents of mammalian protein glycosylphosphoinositol anchors.

Authors:  N Singh; R A Zoeller; M L Tykocinski; P B Lazarow; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

8.  Anchoring and degradation of glycolipid-anchored membrane proteins by L929 versus by LM-TK- mouse fibroblasts: implications for anchor biosynthesis.

Authors:  N Singh; D Singleton; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Biosynthesis of glycosyl-phosphatidylinositol lipids in Trypanosoma brucei: involvement of mannosyl-phosphoryldolichol as the mannose donor.

Authors:  A K Menon; S Mayor; R T Schwarz
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.